alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Annual Report of Novex Systems International, Inc.
("the Company") on Form 10-KSB/A for the twelve month period ended May 31, 2003,
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Daniel W. Dowe, the Chief Executive Officer/President and Chief
Financial Officer of the Company, pursuant to 18 U.S.C. ss.1350, as adopted
pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, certify that:

      (1)   The Report fully complies with the requirements of Section 13(a) and
            Section 15(d) of the Securities and Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operation
            of the Company.


                                                By: /s/ Daniel W. Dowe
                                                    ---------------------------
                                                    Daniel W. Dowe
                                                    Chief Executive Officer and
                                                    Chief Financial Officer

                                                Date: December 22, 2003


                                       29
§ 251.11 Official contact and U.S. agent for Foreign Sellers. ( a ) *Official contact.* A Foreign Seller subject to the registration requirements of this part must designate an official contact. The official contact is responsible for: ( 1 ) Ensuring the accuracy of registration information as required by § 251.9; and
( 2 ) Reviewing, disseminating, routing, and responding to all communications from FDA, including emergency communications.
( b ) *U.S. agent.* ( 1 ) A Foreign Seller must designate a single U.S. agent. The U.S. agent must reside or maintain a place of business in the United States and may not be a mailbox, answering machine or service, or other place where a person acting as the U.S. agent is not physically present. The U.S. agent is responsible for: ( i ) Reviewing, disseminating, routing, and responding to all communications from FDA, including emergency communications;
( ii ) Responding to questions concerning those drugs that are imported or offered for import to the United States; and
( iii ) Assisting FDA in scheduling inspections.
( 2 ) FDA may provide certain information and/or documents to the U.S. agent. The provision of information and/or documents by FDA to the U.S. agent is equivalent to providing the same information and/or documents to the Foreign Seller.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1996
<PERIOD-START>                             APR-01-1995
<PERIOD-END>                               DEC-31-1995
<CASH>                                           2,153
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 2,168
<PP&E>                                          18,948
<DEPRECIATION>                                   9,074
<TOTAL-ASSETS>                                  42,457
<CURRENT-LIABILITIES>                          474,156
<BONDS>                                              0
<PREFERRED-MANDATORY>                           20,508
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   (569,762)
<TOTAL-LIABILITY-AND-EQUITY>                    42,457
<SALES>                                         17,211
<TOTAL-REVENUES>                                17,211
<CGS>                                                0
<TOTAL-COSTS>                                   77,248
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (60,037)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (60,037)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (60,037)
<EPS-PRIMARY>                                   (0.01)
<EPS-DILUTED>                                   (0.01)
        

</TABLE>
#### Phillip Algozino, Plaintiff-Appellee, v. Police Board of the City of Chicago, Illinois, and James B. Conlisk, Jr., Superintendent of Police of the City of Chicago, and O. W. Wilson, Defendants-Appellants.

Gen. No. 53,309. (Abstract of Decision.)

First District, First Division.

June 6,1969.

Raymond F. Simon, Corporation Counsel of the City of Chicago (Marvin E. Aspen and Marsile J. Hughes, Assistant Corporation Counsel, of counsel), for appellants; No brief filed for appellee.

Opinion by JUSTICE MURPHY. Not to be published in full.
§ 1401.7 Responses—form and content. ( a ) *Determinations.* The General Counsel, or designee, will determine within 20 days (excepting Saturdays, Sundays, and legal public holidays) after the receipt of a FOIA request whether it is appropriate to grant the request and will provide written notification to the person making the request. The notification shall also advise the person making the request of any fees assessed under § 1401.11 through 13. ONDCP will inform the requester of the availability of its FOIA Public Liaison.
( b ) *Tracking number.* ONDCP will assign it an individualized tracking number if it will take longer than 10 working days to process and may assign such a tracking number for less than 10 working days at our discretion.
( c ) *Adverse determinations.* If ONDCP makes an adverse determination denying a request in any respect, it must notify the requester of that determination in writing. Adverse determinations, or denials of requests, include decisions that: The requested record is exempt, in whole or in part; the request does not reasonably describe the records sought; the information requested is not a record subject to the FOIA; the requested record does not exist, cannot be located, or has been destroyed; or the requested record is not readily reproducible in the form or format sought by the requester. Adverse determinations also include denials involving fees or fee waiver matters or denials of requests for expedited processing.
( d ) *Content of denial.* The denial must be signed by the head of the agency or designee and must include: ( 1 ) The name and title or position of the person responsible for the denial;
( 2 ) A brief statement of the reasons for the denial, including any FOIA exemption applied by the agency in denying the request;
( 3 ) An estimate of the volume of any records or information withheld, such as the number of pages or some other reasonable form of estimation, although such an estimate is not required if the volume is otherwise indicated by deletions marked on records that are disclosed in part or if providing an estimate would harm an interest protected by an applicable exemption; and
( 4 ) A statement that the denial may be appealed to the Director or his/her designee within 90 days of the date of the response. The requirements for making an appeal are specified in § 1401.10.
( 5 ) A statement notifying the requester of the assistance available from the agency's FOIA Public Liaison and the dispute resolution services offered by OGIS.
§ 212.30 What requirements must my facilities and equipment meet? ( a ) *Facilities.* You must provide adequate facilities to ensure the orderly handling of materials and equipment, the prevention of mix-ups, and the prevention of contamination of equipment or product by substances, personnel, or environmental conditions that could reasonably be expected to have an adverse effect on product quality.
( b ) *Equipment procedures.* You must implement procedures to ensure that all equipment that could reasonably be expected to adversely affect the identity, strength, quality, or purity of a PET drug, or give erroneous or invalid test results when improperly used or maintained, is clean, suitable for its intended purposes, properly installed, maintained, and capable of repeatedly producing valid results. You must document your activities in accordance with these procedures.
( c ) *Equipment construction and maintenance.* Equipment must be constructed and maintained so that surfaces that contact components, in-process materials, or PET drugs are not reactive, additive, or absorptive so as to alter the quality of PET drugs.
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

JAMES R. GOODMAN

, Appellant,

v.

PALADIN FUND II, LLC

, Appellee

.

No. 4D 17

- 2084

[ February 8, 2018 ]

Appeal from the Circuit Court for the Nineteenth Judicial Circuit, St.

Lucie County ; Robert E. Belanger , Judge; L.T. Case No. 562011

- CA

003406

.

Stephen C. Breuer of Moffa & Breuer, PLLC, Plantation, for appellant.

Avri Ben

- Hamo of Greenfield Law Group, P.A., Boca Raton, for appellee.

P ER C URIAM

.

Affirmed.

W ARNER

, M AY and D AMOORGIAN

, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
#### § 1010.1 Scope.

The standards listed in this subchapter are prescribed pursuant to section 534 of Subchapter C—Electronic Product Radiation Control of the Federal Food, Drug, and Cosmetic Act (formerly the Radiation Control for Health and Safety Act of 1968) (21 U.S.C. 360kk) and are applicable to electronic products as specified herein, to control electronic product radiation from such products. Standards so prescribed are subject to amendment or revocation and additional standards may be prescribed as are determined necessary for the protection of the public health and safety.

[73 FR 34861, June 19, 2008]
<PAGE>   1
 
                                                                    EXHIBIT 23.1
 
               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
 
   
     We consent to the reference to our firm under the captions "Selected
Financial Data" and "Experts" and to the use of our report dated January 31,
1997, except for paragraph 1 of Note 11, as to which the date is
               , 1997, in Amendment No. 2 to the Registration Statement (Form
S-1) and related Prospectus of Corixa Corporation for the registration of
3,162,500 shares of its Common Stock.
    
 
Seattle, Washington
 
--------------------------------------------------------------------------------
 
     The foregoing consent is in the form that will be signed upon the
completion of the reverse stock split described in paragraph 1 of Note 11 to the
financial statements.
 
                                                 /s/ ERNST & YOUNG LLP
 
Seattle, Washington
   
September 19, 1997
<PAGE>   1

                                                                    Exhibit 24.1


                                POWER OF ATTORNEY


         KNOW ALL MEN BY THESE PRESENTS, the person whose signature appears
below constitutes and appoints Yehoram Uziel attorney-in-fact, for him, with the
power of substitution, in any and all capacities, to sign the Registration
Statement on Form S-8 for 1,500,000 shares issuable under the Soligen
Technologies, Inc. 1993 Stock Option Plan, as amended, and any amendments to
such Registration Statement (including post-effective amendments), and to file
exhibits thereto and other documents in connection therewith with the Securities
and Exchange Commission, granting unto said attorney-in-fact full power and
authority to do or perform each and every act and thing requisite or necessary
to be done in and about the premises, as fully to all intents and purposes as he
might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact or substitute may lawfully do or cause to be done by virtue
hereof.


                                             /s/ Dr. Mark W. Dowley
                                             -----------------------------------
                                             Dr. Mark W. Dowley
#### BURNS *v.*BOARD OF ELECTION COMMISSIONERS.

Elections — Nominations—Conventions—Proceedings.

A candidate receiving 6 of 11 votes of the regularly elected delegates in a regularly constituted convention, as against a candidate receiving 5 votes in a seceding body of 5, is the nominee of the convention and is entitled to the place on the regular party ticket.

Mandamus by William R. Borns to compel the boards of election commissioners of Alger, Luce, Schoolcraft, and Mackinac counties to place relator’s name upon the official republican ballot as a candidate for representative in the State legislature.

Submitted October 27, 1908.

(Calendar No. 23,099.)

Writ granted October 27, 1908.

*George P. Brown,*for relator.

*James McNamara,*for respondents.

Per Curiam.

The record shows that relator received 6 of 11 votes of the regularly elected delegates in a regularly constituted convention. Respondent Edward McNamara received 5 votes in a seceding body of 5. Under these circumstances, it is clear that relator is entitled to a place on the regular republican ticket, and that respondent is entitled to no place upon the official ballot. *Beck*v. *Election Com'rs,*103 Mich. 192; *Potter*v. *Deuel,*149 Mich. 393.
§ 21.50 Procedures for submitting requests for amendment of records. ( a ) An individual who received access to a record about himself under subpart D of this part may request that the record be amended if he believes that the record or an item of information is not accurate, relevant to a Food and Drug Administration purpose, timely, or complete.
( b ) Amendments under this subpart shall not violate existing statute, regulation, or administrative procedure. ( 1 ) This subpart does not permit alteration of evidence presented in the course of judicial proceedings or Food and Drug Administration adjudicatory or rule making proceedings or collateral attack upon that which has already been the subject of any such proceedings.
( 2 ) If the accuracy, relevancy, timeliness, or completeness of the records may be contested in any other pending or imminent agency proceeding, the Food and Drug Administration may refer the individual to the other proceeding as the appropriate means to obtain relief. If the accuracy, relevance, timeliness, or completeness of a record is, or has been, an issue in another agency proceeding, the request under this section shall be disposed of in accordance with the decision in the other proceeding, absent unusual circumstances.
( c ) Requests to amend records shall be submitted, in writing, to the FDA Privacy Act Coordinator in accordance with § 21.40(b). Such requests shall include information sufficient to enable the Food and Drug Administration to locate the record, a brief description of the items of information requested to be amended, and the reasons why the record should be amended together with any appropriate documentation or arguments in support of the requested amendment. An edited copy of the record showing the described amendment may be included. Verification of identity should be provided in accordance with § 21.44.
( d ) Written acknowledgement of the receipt of a request to amend a record shall be provided within 10 working days to the individual who requested the amendment. Such acknowledgement may request any additional information needed to verify identity or make a determination. No acknowledgement need be made if the request can be reviewed, processed, and the individual notified of the agency's agreement with the request or refusal within the 10-day period.
[42 FR 15626, Mar. 22, 1977, as amended at 46 FR 8459, Jan. 27, 1981]
## Beforethe United States Department ofTransportation·· 

# Washington, DC

January 7, 2015

EssentialAirService at: EL CENTRO/IMPERIAL, CALIFORNIA Docket OST-2008-0299 under49 U.S.C. 41731 et.seq. This document contains Great Lakes Aviation, Ltd.'s response to Order Requesting Proposals 2014-12-2. Great LakesAviation, Ltd. is pleased to submitthis proposal to provide essential air transportation at El Centro/Imperial, California. The attached proposal contemplates the use of pressurized 30 seat Embraer EMB-120 Brasilia aircraft. Great Lakes has been operating the Brasilia since 1994 and beleives it itwell suited to servethe market. The Company has been developing a Los Angeles (LAX) hub forthe last several years and utilizes gate facilities in Terminal 6. With security screeening accomplished atthe El CentroImperial airport, passengerswill conveniently connectto American, Delta and United without being required to visit a LAX checkin counteror passengersecurity processes. Great Lakes' proposal contemplates non-stop, convenientlytimed connecting services with our code share partner, United Airlines, at the LAX hub. In addition to ourcode share agreement with UnitedAirlines, Great Lakes maintains electronic interline ticketing and baggage agreementsAmerican, Delta and United. Customerswill also be eligiblefor Delta Sky Miles Frequent Flyerprogram when travel is booked through Delta's sales channels. All ofwhich will offer El Centro/Imperial passengers maximum access to the domestic and international air transportation system. Questions and comments may be referred to: Michael Matthews Chief Financial Officer Great LakesAirlines 1022 Airport Parkway Cheyenne, 

### VVY 82001 (307) 432-7000

# Great Lakes Aviation, Ltd. Annual Compensation Requirements for Essential Air Service at 

# El Centro/Imperial California to Los Angeles, California (LAX ) Two Round Trips - 30 SeatAircraft 97.5% completion factor Departures: Block Hours: Revenue Passenger Miles: Available Seat Miles: Operating Revenues: Passenger: IPL-LAX 

### 12,000 psgrs at $72.54 $870,480

Other: (at 0.62% ofpassenger revenue) Total Operating Revenues: Operating Expenses: Direct: Aircraft and Hull Insurance Fuel and Oil Flying Operations Maintenance Total Direct Expenses: Total Indirect Expenses: Total Operating Expenses: Operating Loss Profit Element (5.0% ofTotal Operating Expenses) Annual Compensation Requirement:
No UplineScheduling Restrictions 

### $5,397

$365,975 $665,845 $291,983 $550,960 1,217 1,217 2,172,000 6,608,310

$875,877

$1,874,763

$946,951 $2,821,713 ($1 

### ,945,836) $141,086 $2,086,922*** Sample Schedules 30 SeatAircraft*** *** [IPL] EL CENTRO/IMPERIAL, CALIFORNIA **•

-------------------- 0 E P A R T U R E S -------------------- -------------------- A R R IV A L S --------------------

FLT OPT ARR TO EQP FREQ FLT EQP FREQ FROM OPT ARR 7271 645 745 LAX 30 Seat X? non stop 7272 30 Seat X? LAX 1155 1255 non stop 7275 1330 1430 LAX 30 Seat X6 non stop 7278 30 Seat X6 LAX 1645 1745 non stop

No Upline Scheduling Restrictions
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the annual report on Form 10-K of Amerityre Corporation (the "Company") for the year ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gary N. Benninger, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  /s/Gary N. Benninger
Gary N. Benninger
Chief Executive Officer
September 12, 2008
[Federal Register Volume 75, Number 36 (Wednesday, February 24, 2010)]
[Notices]
[Pages 8414-8415]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3615]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[Disaster Declaration <greek-i> 12033]


Tennessee Disaster <greek-i> TN-00036 Declaration of Economic 
Injury

AGENCY: U.S. Small Business Administration.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice of an Economic Injury Disaster Loan (EIDL) 
declaration for the State of Tennessee, dated 02/16/2010.
    Incident: Polk County Rock Slide.
    Incident Period: 11/10/2009 and continuing.

Effective Date: 02/16/2010.
    EIDL Loan Application Deadline Date: 11/16/2010.

ADDRESSES: Submit completed loan applications to: U.S. Small Business 
Administration, Processing and Disbursement Center, 14925 Kingsport 
Road, Fort Worth, TX 76155.

FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster 
Assistance,

[[Page 8415]]

U.S. Small Business Administration, 409 3rd Street, SW., Suite 6050, 
Washington, DC 20416.

SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of 
the Administrator's EIDL declaration, applications for economic injury 
disaster loans may be filed at the address listed above or other 
locally announced locations.
    The following areas have been determined to be adversely affected 
by the disaster:

Primary Counties: Polk.
Contiguous Counties: Tennessee: Bradley, McMinn, Monroe.
    Georgia: Fannin, Murray.
    North Carolina: Cherokee.
    The Interest Rates are:

------------------------------------------------------------------------
                                                                Percent
------------------------------------------------------------------------
Businesses & Small Agricultural Cooperatives Without Credit        4.000
 Available Elsewhere.........................................
Non-Profit Organizations Without Credit Available Elsewhere..      3.000
------------------------------------------------------------------------

    The number assigned to this disaster for economic injury is 120330.
    The States which received an EIDL Declaration <greek-i> are 
Tennessee, Georgia, North Carolina.

(Catalog of Federal Domestic Assistance Number 59002)

    Dated: February 16, 2010.
Karen G. Mills,
Administrator.
[FR Doc. 2010-3615 Filed 2-23-10; 8:45 am]
BILLING CODE 8025-01-P
EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

           In connection with the Quarterly Report of CirTran Corporation on
Form 10-QSB for the period ending March 31, 2002, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), Iehab Hawatmeh,
President and Chief Executive Officer of the Company, certifies, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.

December 23, 2002

                                        /s/ Iehab Hawatmeh
                                      ------------------------------------------
                                      Iehab Hawatmeh
                                      President and Chief Executive Officer